These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23786783)

  • 1. Interferon versus methotrexate in intermediate uveitis with macular edema: results of a randomized controlled clinical trial.
    Mackensen F; Jakob E; Springer C; Dobner BC; Wiehler U; Weimer P; Rohrschneider K; Fiehn C; Max R; Storch-Hagenlocher B; Becker MD
    Am J Ophthalmol; 2013 Sep; 156(3):478-486.e1. PubMed ID: 23786783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema.
    Taylor SR; Habot-Wilner Z; Pacheco P; Lightman SL
    Ophthalmology; 2009 Apr; 116(4):797-801. PubMed ID: 19344827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of inflammatory cystoid macular edema.
    Tranos PG; Tsaousis KT; Vakalis AN; Asteriades S; Pavesio CE
    Retina; 2012 Sep; 32(8):1624-8. PubMed ID: 22481481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.
    ; Kempen JH; Altaweel MM; Drye LT; Holbrook JT; Jabs DA; Sugar EA; Thorne JE
    Ophthalmology; 2015 Oct; 122(10):1967-75. PubMed ID: 26298715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.
    Vujosevic S; Bottega E; Casciano M; Pilotto E; Convento E; Midena E
    Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical difluprednate monotherapy for uveitic macular edema.
    Symes RJ; Forooghian F
    Can J Ophthalmol; 2016 Feb; 51(1):47-9. PubMed ID: 26874159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. intravitreal tumor necrosis factor inhibitors in the treatment of refractory diabetic macular edema: a pilot study from the Pan-American Collaborative Retina Study Group.
    Wu L; Hernandez-Bogantes E; Roca JA; Arevalo JF; Barraza K; Lasave AF
    Retina; 2011 Feb; 31(2):298-303. PubMed ID: 21099452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of macular edema on visual function in intermediate, posterior, and panuveitis.
    Taylor SR; Lightman SL; Sugar EA; Jaffe GJ; Freeman WR; Altaweel MM; Kozak I; Holbrook JT; Jabs DA; Kempen JH
    Ocul Immunol Inflamm; 2012 Jun; 20(3):171-81. PubMed ID: 22530874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Ozurdex implant in treatment of noninfectious intermediate uveitis.
    Palla S; Biswas J; Nagesha CK
    Indian J Ophthalmol; 2015 Oct; 63(10):767-70. PubMed ID: 26655000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of methotrexate in resolving ocular inflammation after specific therapy for presumed latent syphilitic uveitis and presumed tuberculosis-related uveitis.
    Sahin O; Ziaei A
    Retina; 2014 Jul; 34(7):1451-9. PubMed ID: 24531737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Uveitic Macular Edema in the First-line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial.
    Tsui E; Rathinam SR; Gonzales JA; Thundikandy R; Kanakath A; Balamurugan S; Vedhanayaki R; Lim LL; Suhler EB; Al-Dhibi HA; Doan T; Keenan J; Ebert CD; Kim E; Madow B; Porco TC; Acharya NR;
    Ophthalmology; 2022 Jun; 129(6):661-667. PubMed ID: 35143800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.
    ; Kempen JH; Altaweel MM; Holbrook JT; Jabs DA; Louis TA; Sugar EA; Thorne JE
    Ophthalmology; 2011 Oct; 118(10):1916-26. PubMed ID: 21840602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional study of submacular thickening in intermediate uveitis and determination of treatment threshold.
    Simonazzi B; Balaskas K; Guex-Crosier Y
    BMC Ophthalmol; 2016 May; 16(1):59. PubMed ID: 27188332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of tocilizumab therapy for refractory uveitis-related macular edema.
    Mesquida M; Molins B; Llorenç V; Sainz de la Maza M; Adán A
    Ophthalmology; 2014 Dec; 121(12):2380-6. PubMed ID: 25204610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3.
    Rajendram R; Fraser-Bell S; Kaines A; Michaelides M; Hamilton RD; Esposti SD; Peto T; Egan C; Bunce C; Leslie RD; Hykin PG
    Arch Ophthalmol; 2012 Aug; 130(8):972-9. PubMed ID: 22491395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic interventions for macular diseases show characteristic effects on near and distance visual function.
    Munk M; Kiss C; Huf W; Sulzbacher F; Bolz M; Sayegh R; Eisenkölbl S; Simader C; Schmidt-Erfurth U
    Retina; 2013 Oct; 33(9):1915-22. PubMed ID: 23584693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Not Available].
    Ophthalmologe; 2014 Sep; 111(9):814-5. PubMed ID: 25343168
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months.
    Wu L; Arevalo JF; Berrocal MH; Maia M; Roca JA; Morales-Cantón V; Alezzandrini AA; Díaz-Llopis MJ
    Retina; 2010; 30(7):1002-11. PubMed ID: 20616679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Analysis of Uveitis Macular Edema in Multiple Sclerosis Patients Receiving Deep Posterior Sub-Tenon Triamcinolone Acetonide Injection.
    Jovanović S; Šarenac Vulović T; Radotić F; Tončić Z; Živković M; Petrović N
    Ophthalmic Res; 2017; 58(1):1-7. PubMed ID: 28324879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.